Wall Street analyst estimates for AquaBounty Technologies, Inc. (AQB): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
AquaBounty Technologies, Inc. is a biotechnology firm dedicated to boosting productivity within the commercial fish farming sector across the United States and Canada. The company's research initiatives delve into genetics, genomics, fish health, and nutrition. Its flagship offering is AquAdvantage Salmon, a genetically engineered Atlantic salmon intended for human consumption.
Analyst Consensus
| Strong Buy | 0 |
| Buy | 4 |
| Hold | 2 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 6 |
| Avg rating (1-5) | 0.67 |
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-11-10 | $-1.30 | ||
| 2026-08-06 | $-0.26 | ||
| 2026-05-07 | $-0.20 | ||
| 2026-03-31 | $-3.64 | $-0.52 | -600.0% |
| 2025-10-28 | $-0.36 | $-0.62 | +41.9% |
| 2025-08-05 | $-0.87 | $-0.53 | -64.2% |
| 2025-05-15 | $0.16 | $-0.61 | +126.2% |
| 2025-03-31 | $-21.77 | $-0.61 | -3469.6% |
Valuation Ratios
| Price / Book | 2.03 |
| EV / EBITDA | -3.27 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | $53278 | $84518 | $186738 | $127663 | $1.2M | $3.1M | 0 | 0 | 0 |
| Cost of Revenue | $153996 | $235723 | $921542 | $3.6M | $6.7M | $10.8M | $13.6M | $15.3M | 0 | 0 |
| Gross Profit | -$154000 | $2501 | $6363 | -$3.4M | -$6.6M | -$9.6M | -$10.5M | -$15.3M | 0 | 0 |
| Research & Development | $3.4M | $3.4M | $3.5M | $2.4M | $2.4M | $2.1M | $903981 | $506243 | $203296 | 0 |
| Selling, General & Admin | $4.6M | $4.7M | $4.4M | $7.4M | $7.3M | $10.4M | $10.9M | $13.2M | $9.2M | $4.0M |
| Operating Expenses | $8.1M | $9.2M | $10.4M | $9.8M | $9.7M | $12.5M | $11.8M | -$1.6M | $9.6M | $4.0M |
| Operating Income | -$8.1M | -$9.2M | -$10.4M | -$13.2M | -$16.2M | -$22.1M | -$22.3M | -$13.7M | -$9.6M | -$4.0M |
| EBITDA | -$7.9M | -$9.1M | -$9.5M | -$11.9M | -$14.8M | -$20.2M | -$19.8M | -$11.4M | -$8.7M | -$2.0M |
| Interest Expense | $402554 | $21537 | $22257 | $62988 | $152367 | $316442 | $291177 | $303967 | $2.3M | $206052 |
| Pre-tax Income | -$8.5M | -$9.3M | -$10.4M | -$13.2M | -$16.4M | -$22.3M | -$22.2M | -$13.8M | -$11.4M | -$2.2M |
| Income Tax | 0 | $15585 | $5994 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -$8.5M | -$9.3M | -$10.4M | -$13.2M | -$16.4M | -$22.3M | -$22.2M | -$27.6M | -$149.2M | -$18.5M |
| EPS | $-31.95 | $-21.11 | $-18.80 | $-13.20 | $-9.00 | $-6.40 | $-6.20 | $-7.17 | $-38.65 | $-4.77 |
| EPS (Diluted) | $-31.95 | $-21.11 | $-18.80 | $-13.20 | $-9.00 | $-6.40 | $-6.20 | $-7.17 | $-38.65 | $-4.77 |
| Shares Outstanding (Diluted) | $265156 | $438625 | $651438 | $1.0M | $1.8M | $3.5M | $3.6M | $3.8M | $3.9M | $3.9M |
Price
| Price | $1.11 |
| Market Cap | $6M |
| Exchange | NASDAQ |
| Country | US |
Related companies: AGRI · AMZE · EDBL · EEIQ · GNLN · GSUN · IBG
Explore sector: Consumer Defensive · Agricultural Farm Products
More sections of AQB: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks